NFKB1 and neoplasm: In our previous studies, we found that the HRASV12 mutation conferred tumour-initiating activity, a hallmark of CSCs, in p53−/− MEFs26, and this phenomenon was completely dependent on NF-κB-induced aerobic glycolysis13.